nbiomics

NBiomics is at the forefront of biotechnology research, pioneering new protocols in the synthesis of nano electronics, genomics, and proteomics to revolutionize the detection and treatment of cancer and other diseases. Located in Arlington, Texas, NBiomics is uniquely positioned to contribute significantly to this rapidly evolving field.

With a focus on early cancer detection, NBiomics aims to improve disease management, prognosis, and patient survival rates. Their innovative approach involves the specific isolation of circulating tumor cells using nano-textured aptamer-functionalized microfluidic devices, placing NBiomics at the heart of the next-generation cancer diagnostics market. The primary address of NBiomics is in Arlington, Texas.

NBiomics is dedicated to producing a device capable of detecting cancer by enumerating circulating tumor cells long before clinical symptoms appear. This technology holds immense potential for in vitro/point-of-care diagnostics. NBiomics is committed to innovation and excellence in biotechnology research. Management is working to complete further details about the company. We invite the manager of NBiomics to create a customized and exclusive company showcase and product listing on our platform.